Search | Virtual Health Library

1.

Dacomitinib compared with placebo in pretreated patients with advanced or metastatic non-small-cell lung cancer (NCIC CTG BR.26): a double-blind, randomised, phase 3 trial.

Ellis, Peter M; Shepherd, Frances A; Millward, Michael; Perrone, Francesco; Seymour, Lesley; Liu, Geoffrey; Sun, Sophie; Cho, Byoung Chul; Morabito, Alessandro; Leighl, Natasha B; Stockler, Martin R; Lee, Christopher W; Wierzbicki, Rafal; Cohen, Victor; Blais, Normand; Sangha, Randeep S; Favaretto, Adolfo G; Kang, Jin Hyoung; Tsao, Ming-Sound; Wilson, Carolyn F; Goldberg, Zelanna; Ding, Keyue; Goss, Glenwood D; Bradbury, Penelope Ann.

Lancet Oncol ; 15(12): 1379-88, 2014 Nov.

Article in English | MEDLINE | ID: mdl-25439692

2.

Can a computerized format replace a paper form in PRO and HRQL evaluation? Psychometric testing of the computer-assisted LCSS instrument (eLCSS-QL).

Hollen, Patricia J; Gralla, Richard J; Stewart, John A; Meharchand, Jacinta M; Wierzbicki, Rafal; Leighl, Natasha.

Support Care Cancer ; 21(1): 165-72, 2013 Jan.

Article in English | MEDLINE | ID: mdl-22684988

3.

A phase II, multicenter study of cetuximab monotherapy in patients with refractory, metastatic colorectal carcinoma with absent epidermal growth factor receptor immunostaining.

Wierzbicki, Rafal; Jonker, Derek J; Moore, Malcolm J; Berry, Scott R; Loehrer, Patrick J; Youssoufian, Hagop; Rowinsky, Eric K.

Invest New Drugs ; 29(1): 167-74, 2011 Feb.

Article in English | MEDLINE | ID: mdl-19830388

4.

Cetuximab for the treatment of colorectal cancer.

Jonker, Derek J; O'Callaghan, Chris J; Karapetis, Christos S; Zalcberg, John R; Tu, Dongsheng; Au, Heather-Jane; Berry, Scott R; Krahn, Marianne; Price, Timothy; Simes, R John; Tebbutt, Niall C; van Hazel, Guy; Wierzbicki, Rafal; Langer, Christiane; Moore, Malcolm J.

N Engl J Med ; 357(20): 2040-8, 2007 Nov 15.

Article in English | MEDLINE | ID: mdl-18003960

5.

Micro cantilever movement detection with an amorphous silicon array of position sensitive detectors.

Contreras, Javier; Costa, Daniel; Pereira, Sonia; Fortunato, Elvira; Martins, Rodrigo; Wierzbicki, Rafal; Heerlein, Holger; Ferreira, Isabel.

Sensors (Basel) ; 10(9): 8173-84, 2010.

Article in English | MEDLINE | ID: mdl-22163648

6.

A Randomized, Open-Label Phase II Trial of Volasertib as Monotherapy and in Combination With Standard-Dose Pemetrexed Compared With Pemetrexed Monotherapy in Second-Line Treatment for Non-Small-Cell Lung Cancer.

Ellis, Peter M; Leighl, Natasha B; Hirsh, Vera; Reaume, M Neil; Blais, Normand; Wierzbicki, Rafal; Sadrolhefazi, Behbood; Gu, Yu; Liu, Dan; Pilz, Korinna; Chu, Quincy.

Clin Lung Cancer ; 16(6): 457-65, 2015 Nov.

Article in English | MEDLINE | ID: mdl-26100229

7.

Mapping the complex morphology of cell interactions with nanowire substrates using FIB-SEM.

Wierzbicki, Rafal; Købler, Carsten; Jensen, Mikkel R B; Lopacinska, Joanna; Schmidt, Michael S; Skolimowski, Maciej; Abeille, Fabien; Qvortrup, Klaus; Mølhave, Kristian.

PLoS One ; 8(1): e53307, 2013.

Article in English | MEDLINE | ID: mdl-23326412

8.

A randomized phase 2 study of paclitaxel and carboplatin with or without conatumumab for first-line treatment of advanced non-small-cell lung cancer.

Paz-Ares, Luis; Bálint, Beatrix; de Boer, Richard H; van Meerbeeck, Jan P; Wierzbicki, Rafal; De Souza, Paul; Galimi, Francesco; Haddad, Vincent; Sabin, Tony; Hei, Yong-jiang; Pan, Yang; Cottrell, Susan; Hsu, Cheng-Pang; RamLau, Rodryg.

J Thorac Oncol ; 8(3): 329-37, 2013 Mar.

Article in English | MEDLINE | ID: mdl-23370314

9.

Cell motility, morphology, viability and proliferation in response to nanotopography on silicon black.

Lopacinska, Joanna M; Gradinaru, Cristian; Wierzbicki, Rafal; Købler, Carsten; Schmidt, Michael S; Madsen, Martin T; Skolimowski, Maciej; Dufva, Martin; Flyvbjerg, Henrik; Mølhave, Kristian.

Nanoscale ; 4(12): 3739-45, 2012 Jun 21.

Article in English | MEDLINE | ID: mdl-22614757

10.

Sunitinib plus erlotinib versus placebo plus erlotinib in patients with previously treated advanced non-small-cell lung cancer: a phase III trial.

Scagliotti, Giorgio V; Krzakowski, Maciej; Szczesna, Aleksandra; Strausz, Janos; Makhson, Anatoly; Reck, Martin; Wierzbicki, Rafal F; Albert, Istvan; Thomas, Michael; Miziara, Jose Elias Abrao; Papai, Zsolt S; Karaseva, Nina; Thongprasert, Sumitra; Portulas, Elsa Dalmau; von Pawel, Joachim; Zhang, Ke; Selaru, Paulina; Tye, Lesley; Chao, Richard C; Govindan, Ramaswamy.

J Clin Oncol ; 30(17): 2070-8, 2012 Jun 10.

Article in English | MEDLINE | ID: mdl-22564989

11.

Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer.

Di Maio, Massimo; Leighl, Natasha B; Gallo, Ciro; Feld, Ronald; Ciardiello, Fortunato; Butts, Charles; Maione, Paolo; Gebbia, Vittorio; Morgillo, Floriana; Wierzbicki, Rafal; Favaretto, Adolfo; Alam, Yasmin; Cinieri, Saverio; Siena, Salvatore; Bianco, Roberto; Riccardi, Ferdinando; Spatafora, Mario; Ravaioli, Alberto; Felletti, Raffaella; Fregoni, Vittorio; Genestreti, Giovenzio; Rossi, Antonio; Mancuso, Gianfranco; Fasano, Morena; Morabito, Alessandro; Tsao, Ming Sound; Signoriello, Simona; Perrone, Francesco; Gridelli, Cesare.

J Thorac Oncol ; 7(12): 1830-1844, 2012 Dec.

Article in English | MEDLINE | ID: mdl-23154555

12.

First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial.

Gridelli, Cesare; Ciardiello, Fortunato; Gallo, Ciro; Feld, Ronald; Butts, Charles; Gebbia, Vittorio; Maione, Paolo; Morgillo, Floriana; Genestreti, Giovenzio; Favaretto, Adolfo; Leighl, Natasha; Wierzbicki, Rafal; Cinieri, Saverio; Alam, Yasmin; Siena, Salvatore; Tortora, Giampaolo; Felletti, Raffaella; Riccardi, Ferdinando; Mancuso, Gianfranco; Rossi, Antonio; Cantile, Flavia; Tsao, Ming-Sound; Saieg, Mauro; da Cunha Santos, Gilda; Piccirillo, Maria Carmela; Di Maio, Massimo; Morabito, Alessandro; Perrone, Francesco.

J Clin Oncol ; 30(24): 3002-11, 2012 Aug 20.

Article in English | MEDLINE | ID: mdl-22778317

13.

Randomized phase II study of gefitinib compared with placebo in chemotherapy-naive patients with advanced non-small-cell lung cancer and poor performance status.

Goss, Glenwood; Ferry, David; Wierzbicki, Rafal; Laurie, Scott A; Thompson, Joyce; Biesma, Bonne; Hirsch, Fred R; Varella-Garcia, Marileila; Duffield, Emma; Ataman, Ozlem U; Zarenda, Marc; Armour, Alison A.

J Clin Oncol ; 27(13): 2253-60, 2009 May 01.

Article in English | MEDLINE | ID: mdl-19289623

14.

Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.

Fuchs, Charles S; Marshall, John; Mitchell, Edith; Wierzbicki, Rafal; Ganju, Vinod; Jeffery, Mark; Schulz, Joseph; Richards, Donald; Soufi-Mahjoubi, Raoudha; Wang, Benjamin; Barrueco, José.

J Clin Oncol ; 25(30): 4779-86, 2007 Oct 20.

Article in English | MEDLINE | ID: mdl-17947725

15.

Culture of Hansens bacilli in vitro in a case of lepromatous leprosy

Massalski, Wandalin Kazimierz; Shukla, Rahma Raksha; Lewenstein, Wieslaw; Wierzbicki, Rafal.

s.l; s.n; 1978. 2 p. ilus.

Non-conventional in English | SES-SP, HANSEN, Hanseníase (leprosy), SESSP-ILSLACERVO, SES-SP | ID: biblio-1231621

Virtual Health Library

Hypertension

Your selection (0)

Export format:

Export: